Funding Announcements

"The founders demonstrated a strong grasp of the clinical and commercial needs in this space. Their technology addresses an important issue that resonates strongly with our investors, who are committed to backing impactful innovation. We’re thrilled to welcome Virilitas Labs into the ACG portfolio and support their next stage of growth."

"Facilities management is the invisible backbone of every building – but the technology behind it hasn’t kept up and has lacked the innovation needed. We built Tyten to solve that, working hand in hand with technicians and help desk teams to understand their real challenges."

"Completing our seed round marks another significant step in StirlingX's growth. The confidence shown by our investors allows us to push further and faster in delivering sovereign, secure technology to partners across critical infrastructure and defence. With strong momentum behind us, we are well positioned to scale and deepen our impact across the markets we serve."

"We are very pleased to complete our investment in Moralbox, which is the third investment from our Venture Sunderland Fund. The Fund supports innovative and scalable businesses with ambitious teams in Sunderland at all stages of their development. Moralbox is developing impressive AI powered training management software and is already working with well-established customers in key industries. We look forward to working with Gordon, John, Steve and the entire Moralbox team to accelerate the company’s growth."

"Our machine could pick up cancer, HIV or sepsis earlier – any disease with a nucleic acid trace. We’re made of DNA – that’s the source code. If you can pick up traces of faults and errors in that code, you can detect problems across the board before symptoms appear. We’ve built the ultimate needle-in-a-haystack detector – a tool that we can put in the hands of scientists to enable the discoveries of tomorrow."